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Commentary
Epigenetic links genetics and envi-ronment in shaping several physio-
logical mechanisms including endocrine 
functions. Growing evidences suggest 
an interplay among endocrine system, 
environment, and epigenetics in the eti-
ology of many complex diseases, includ-
ing some neuropsychiatric disorders. 
We have demonstrated that a prenatal 
exposure to polychlorinated biphenyls 
(PCBs) is able to modulate some epi-
genetic marks related to the steroid 
receptors, which (in particular andro-
gen receptor, AR) are cofactors of his-
tone remodeling enzymes; in our recent 
paper we focused on the interaction 
between PCBs–AR and the demethyl-
ase Jarid1b. Our studies indicate that 
PCBs induce AR transactivation in a 
dose-dependent way. Jarid1b potenti-
ates transcriptional activity indepen-
dently of ligand and of cell phenotype; 
in particular, Jarid1b increase the AR 
transactivation in the isoforms with a 
short polyQ expansion, which are nor-
mally present in the population. Since 
an inverse relationship appears to exist 
between the AR transcriptional activity 
and the polyQ repeat length, it is pos-
sible to hypothesize that Jarid1b–AR 
interaction strength depends on the 
polyQ lenght. PCBs auto-downregu-
late AR expression and this negative 
feedback is potentiated by Jarid1b and 
depends on AR promoter length. These 
results open new perspectives in the 
PCBs/AR/Jarid1b interplay possibly 
occurring in the pathogenesis of some 
neurological diseases like autism.
Epigenetics represents the program-
ming of the genome to express the appro-
priate set of genes in specific cells at 
specific time points during life. Epigenetic 
patterns are generated during cellular dif-
ferentiation by a highly programmed and 
organized process. Nevertheless, they are 
dynamic and responsive to the environ-
ment especially during the critical periods 
of gestation and early life. The epigenome 
is constituted by a set of chromatin regu-
lators, such as DNA methylation, histone 
modifications, nucleoside remodeling 
and miRNA expression that dynamically 
interact to define a correct transcriptomic 
profile1; epigenetics represents the link 
between genetics and environment in 
shaping the physiological functions.2,3 The 
NIH Roadmap Initiative on epigenetics 
has widened the term “Epigenetics” to 
include “Both heritable changes in gene 
activity and expression but also stable, 
long-term alterations in the transcrip-
tional potential of a cell that are not neces-
sarily heritable” (for more information go 
to http://nihroadmap.nih.gov/epigenom-
ics). These changes might be produced 
in particular by the environment present 
in early life and might affect the health 
influencing the susceptibility to develop 
several diseases, from cancer to mental 
disorder during the entire life span.4 The 
most studied environmental influences 
acting on epigenome are diet, infections, 
wasting, smoking and environmental pol-
lutants, in particular endocrine disruptor 
compounds (EDCs). The exposure to 
compounds with endocrine interfering 
activity5 plays a key role on the epigenome 
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shaping multiple aspects of the endocrine 
function. Several enzymes involved in 
epigenetic key processes, such as histone 
modifying enzymes, are affected and 
modulate the endocrine system. It is also 
known that nuclear steroid receptors 
interact with histone-modifying enzymes 
to regulate gene transcription and chro-
matin remodeling.6 Interestingly, histone 
demethylases, the enzymes that catalyze 
the removal of the methyl groups from 
histones, complexes with steroid receptors, 
in particular with the androgen receptor 
(AR), facilitating the transcription of their 
target genes.7
One of the EDCs most studied as an 
epigenome modifier is the phytoestro-
gen genistein, which is able to modulate 
the activity of DNA methyltransferases. 
Moreover, alterations of the DNA meth-
ylation pattern in animals exposed to 
the synthetic estrogen diethylstilbestrol 
(DES) have also been found. Likewise, 
bisphenol A (a plasticizer) is able to dis-
rupt the DNA methylation pattern of 
agouti mice exposed to this pollutant. 
Finally, vinclozolin, a fungicide with 
antiandrogenic activity, transgeneration-
ally affects DNA methylation patterns in 
epydidimal sperm of the first generation 
of animals after parental exposure. These 
data, as well as further evidence present in 
the literature, indicate that some EDCs 
can act transgenerationally disrupting the 
epigenome, in particular when the expo-
sure to these compounds occurs during 
the prenatal and earliest period of life (see8 
for references).
Polychlorinated biphenyls (PCBs) 
belong to EDCs and they are widely pres-
ent in the environment. They were exten-
sively used as dielectric and coolant fluids, 
for example in transformers, capacitors, 
and electric motors. Due to their environ-
mental toxicity and classification as a per-
sistent organic pollutant, PCB production 
was banned by the United States Congress 
in 1979 and by the Stockholm Convention 
on Persistent Organic Pollutants in 2001.9 
PCBs are a group of 209 congeners with 
a broad spectrum of biological and toxic 
effects.10 Because of their different bio-
chemical characteristics, some PCBs are 
classified as dioxin like (DL-PCBs), and 
non-dioxin compounds (NDL-PCBs). 
Many, but not all, effects of DL-PCBs are 
mediated by the activation of the arylhy-
drocarbon receptor (AhR) a transcription 
factor present in several cell types of dif-
ferent animal species, including man. The 
differential effects of these two classes of 
pollutants are not distinguishable in vivo, 
because animals and humans are exposed 
at the same time to both classes and the 
global effect is cumulative.11 Although 
production of PCBs was discontinued 
many years ago, due to their high resis-
tance to degradation, they are still pres-
ent in the environment; chronic low-level 
exposure to PCBs remains a significant 
public health concern. PCBs might have 
direct toxic effects altering gene expres-
sion, particularly during development.12 
Many and diverse endocrine, metabolic 
and behavioral effects have been described 
after PCBs exposure in animals and 
humans.13
Few data are available on the epigen-
etic effects induced by PCBs. It seems that 
an exposure to a mixture containing 14 
mono- and di-ortho PCB congeners, from 
the first day of gestation to the weaning, 
reduces the expression and the activity of 
DNA methyltransferases in the rat off-
spring liver.14
In our previous experiments we found 
that an in utero exposure to a reconsti-
tuted mixture of PCBs (PCB 126, 138, 
153 and 180) is able to induce gene and 
protein expression of H3K4me demeth-
ylase (Jarid1b) and of SIRT1 (HDAC, 
Histone deacetylase) in the liver of 
exposed offspring. Consequently, we 
found an alteration of the H3K4me3 
and H4K16ac contents in the liver of the 
exposed offspring. Moreover, we observed 
also a reduction of AR expression in the 
same animals.
Since, as mentioned before, steroid 
receptors are cofactors of histone remod-
eling enzymes, in our recent paper15 we 
focused the attention on PCBs-AR-Jarid1b 
interaction. Two different levels of PCBs/
AR/Jarid1b interaction were evaluated. 
On one side we investigated how PCBs 
could affect the AR/Jarid1b interaction in 
AR target gene transcription, on the other 
side we analyzed how PCBs could affect 
AR/Jarid1b interaction in modulating the 
AR negative control of its own transcrip-
tion. In particular we have analyzed: (i) 
the AR transcriptional activity induced 
by PCBs; (ii) the role of PCBs and Jarid1b 
in the transactivation of different AR poly 
Q variants (isoforms with different tran-
scriptional activities) and (iii) the role of 
Jarid1b in the AR activation and interac-
tion with the AR promoter.15
PCBs treatment is able to induce AR 
transcriptional activity in a dose-depen-
dent manner, even if the effect is much 
lower than that induced by the natu-
ral ligand, DHT (dihydrotestosterone), 
which is the active 5-α reduced testoster-
one metabolite, possessing a much higher 
affinity for AR than the native hormone, 
testosterone. Ligand binding studies have 
shown a direct and specific binding of sev-
eral PCBs congeners to the ligand–bind-
ing domain of the AR protein.16 Jarid1b 
might modulate the effects of AR ligand 
interaction. The interaction between 
Jarid1b and AR on AR transcriptional 
activity is described in the literature, espe-
cially in prostate cancer17 and has been 
documented in our previous “in vivo” 
studies,9 in which PCBs exposure stimu-
lated the expression of the Jarid1b in the 
rat liver and concomitantly reduced AR 
expression.11
In the studies described in the our 
recent paper15 the overexpression of 
Jarid1b cotransfected with AR increases 
transcriptional activity induced by DHT 
or by PCBs in three different cell types: 
HEK293, and two neuronal cell lines, 
NSC34 and GN11. The effect of Jarid1b 
overexpression is cell-phenotype and 
ligand independent.
The mechanism by which Jarid1b 
potentiates the AR transcriptional activ-
ity or AR nuclear translocation is still 
unclear. It is known that the enhancement 
of the AR transcriptional activity needs 
the preservation of the enzymatic activity, 
because deletion of the JmjC domain, the 
catalytic center of the demethylase, abol-
ishes the stimulation.17,18
The interaction between PCBs and 
AR is also affected by differences in the 
structure of the AR gene present among 
individuals. It is known that AR tran-
scriptional activity depends at least in 
part on the polyglutamine tract (polyQ, 
coded by a CAG repeat) length located 
in the trans-activating region of the AR. 
In the AR gene the CAG repeat number 
vary both within and between human 
www.landesbioscience.com endocrine Disruptors e27347-3
populations between 8 and 30 units19,20 
and thus the coded polyQ also is poly-
morphic in length. An inverse relation-
ship exists between the AR transcriptional 
activity and the poly Q repeat length (AR 
CAGn21-23). Two recent reports by Bjork 
and coworkers24,25 indicate that PCBs have 
a CAG/PolyQ length dependent effect on 
AR “ in vitro”25 and in some human pros-
tatic cells.24 In particular, PCB 153, one 
component of the mixture utilized in our 
studies, has a more pronounced effect on 
the “ in vitro” AR transcriptional activity 
of the short poly Q isoforms. It is possible 
to hypothesize that Jarid1b-AR interac-
tion affects the differential transcriptional 
activity of the AR isoforms as a function 
of the interaction strength which is lower 
for the longer isoform which possess a 
polyQ expansion. Indeed, Suzuki and 
colleagues have shown that the aberrant 
polyQ expansion potentiates the asso-
ciation between Rbp (Retinoblastoma 
Protein) and AR: this association appears 
to attenuate the recruitment of HDAC1 
(an histone deacetylase class 1), a potent 
transcription cofactor.32 It is conceivable 
that a similar mechanism could lead to 
the attenuated interaction shown in our 
studies for the longest isoform ARQ46. 
Conversely, the higher activation of the 
short AR seems mediated by a better inter-
action of this receptor with Jarid1b. This 
hypothesis is illustrated in Figure 1. On 
the left panel is represented the interac-
tion Jarid1 b with the short isoform of AR 
(ARQ12) which potentiates AR transcrip-
tional activity, following the binding of 
PCBs to AhR-AR complex. On the right 
panel the transactivation effect disappears 
since the longer AR isoform (ARQ46) is 
not able to produce a strong interaction 
with Jarid1b. The AR/Jarid1b binding 
on DNA of target gene is allowed by the 
presence of ARE (androgen responsive ele-
ment) and by the presence of a binding site 
for Jarid1b (PLU1). The involvement of 
AhR in the AR transcription mechanism 
produced by PCBs is considered below.
These observations might be impor-
tant in explaining the pathogenesis of 
Autism Spectrum Disorder (ASD) in 
which the genetic as well as important 
environmental effects might be involved. 
Indeed, ASD onset is possibly related to 
an excessive androgen prenatal exposure 
both in animals26 and in humans.27 The 
hyperandrogenization of the brain might 
be caused by a higher fetal androgen expo-
sure, increased activity of testosterone 
(T) activating enzymes or enhanced AR 
activity, as might occur in presence of the 
short polyQ variant of AR and/or by the 
interaction of environmental induced epi-
genetic changes. A hyper-activation of AR 
induced by PCBs in presence of Jarid1b in 
some susceptible individuals, could be an 
important etiological mechanism in this 
complex disease.
Indeed, a higher prevalence of short 
CAG alleles in ASD female subjects has 
been reported,28 and mutations within the 
genes encoding the H3K4-specific histone 
demethylase, JARID1C/SMCX, have 
been linked to autism.29 The AR CAG 
repeat genotype might be one of many 
genetic component interacting with envi-
ronment through epigenome contributing 
to ASD susceptibility. All these data sug-
gest that an early-life exposure to PCBs 
might be involved in modulating AR 
effects through the mechanisms described 
above and/or by the activation of AhR.11,30
Since in previous in vivo studies we 
found that PCBs exposure reduces AR 
expression,11,31,32 the second level of investi-
gation of our recent paper focused on how 
PCBs could affect AR/Jarid1b interaction 
in the modulation of AR negative control of 
its own transcription. Analyzing the DNA 
sequence of the AR promoter, we observed 
the presence of binding sites for Jarid1b 
(PLU1) and AhR (XRE), along with some 
androgen responsive elements (ARE); this 
could be indicative of the possible direct 
effect of the demethylase in modulating the 
AR transactivation induced either by DHT 
or by PCBs also in AR negative feedback.33 
To study this aspect we have cotransfected 
HEK293 cells with plasmids coding for 
Jarid1b and AR promoters with a different 
length (long, intermediate and short) and 
a luciferase reporter gene. The results have 
shown that the effect of PCBs, but not of 
DHT, needs the presence of Jarid1b and 
of at least 2 PLU1 binding sites. Since the 
responsive element XRE, ARE and PLU1 
are concomitantly present on the AR pro-
moter, it is possible that the recruitment 
of Jarid1b is responsible of the complex 
AhR-AR interactions occurring after PCBs 
exposure, in particular in presence of copla-
nar congeners. The association between 
AR and AhR is complex and not fully 
understood.34-36 To our knowledge, there is 
no data about a direct interaction between 
AhR and Jarid 1b, even if in mouse hepa-
toma cells (HEPA-1) the activation of the 
arylhydrocarbon receptor (AhR) produces 
epigenetic changes affecting the acetylation 
of lysine 16 of histone H4 and in the tri-
methylation of lysine 4 of histone H3.37
It is possible to conclude that PCBs 
induced AR modulation involves 
AR-Jarid1b interactions occurring in neu-
ronal cell lines. This mechanism might 
Figure 1. Left panel: the interaction between Jarid1b (green shape) and arQ12 (blue shape) poten-
tiates ar transcriptional activity (green arrow), after the binding of PCBs to ahr (purple shape)-ar 
complex. on the right panel the transactivation effect disappears (red arrow) since arQ46 (blue 
shape) is not able to produce a strong interaction with Jarid1b (green shape). the ar/ahr/Jarid1b 
binding on Dna of target gene is allowed by the presence of are (androgen responsive element, 
blue box) and by the presence of a binding site for Jarid1b (PLU1, green box).
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be involved in the etiology of a complex 
disorder like autism spectrum disorder. 
Further studies are needed to substanti-
ate this hypothesis which involves a fine 
interplay between epigenome, environ-
ment and endocrine system in a complex 
disorder, such as ASD.
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